A new drug arrives to complement the dermaxtologic line.
BIOGEN® announces a new release as part of the products that make up the line of skin care; it is QUINOY®, 4% Hydroquinone cream, in 100g presentation.
Hydroquinone is an effective skin lightener, for the treatment of melasma, chloasma and solar melanosis, among other diseases related to melanin production. Its application should not be indiscriminate; as diagnosis would determine prescription according to various types of skin.
With the arrival of QUINOY®, the portfolio of the company gains presence in the field of dermatology drugs. It will be available in major drug stores around the country.